BMX-IN-1,
BMX-IN-1,
1431525-23-3,
N-[5-[9-[4-(methanesulfonamido)phenyl]-2-oxobenzo[h][1,6]naphthyridin-1-yl]-2-methylphenyl]prop-2-enamide,
BMX kinase inhibitor,
GTPL9269,
CHEMBL4091991,
SCHEMBL17052523,
BDBM102620,
ZINC96173501,
AKOS030526521,
CS-1295,
NCGC00378865-01,
HY-80002,
Example 1-14 [ WO2014063054],
W-6056,
N-[5-[9-[4-(methanesulfonamido)phenyl]-2-oxobenzo[h][1,,
N-[2-Methyl-5-[9-[4-[(methylsulfonyl)amino]phenyl]-2-oxobenzo[h]-1,6-naphthyridin-1(2H)-yl]phenyl]-2-propenamide,
A3260,
A15027,